CD-12 update:

-371 patients
-5-6 patients a day enrolling
-had a record 15 patients enrolled in a single day
-should be finished by this weekend
-because enrollment is so fast, there will be no interim analysis


long-hauler trial update:

-expect "incredible" data
-will do interim analysis after 60 (?) patients
-close to submitting final comments for approval to proceed
-expect 7m patients for this indication, including younger patients
-identified long-hauler MOA


EUA for Philippines:

-not filed yet
-hope to file in a couple weeks with CD10 data (and maybe blinded CD12 data)


NASH update:

-new partnership with a UK diagnostic company for NASH
-believe that we can address both NASH and fatty liver disease


Cancer update:

-5 colon cancer patients (1 deceased)
-2 prostate cancer patients
-5 breast cancer patients
-8 patients are at least 4 months along
-hired new oncologist


HIV update:

-may file with EU (in addition to US, UK, and Canada)
-received detailed feedback on application
-high probability of success


HIV cure:

-developing protocol for trial


Vyrologix once-a-month treatment:

-strong potential for once-a-month treatment for prep


NASDAQ update:

-application is on hold (not rejected)
-still dealing with equity requirement and stock price requirement (and tangible assets requirement)